These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26159242)

  • 1. The impact of initiating rivaroxaban versus low-molecular weight heparin plus warfarin in patients admitted to the hospital for venous thromboembolism.
    Hom L; Sobieraj DM
    Int J Cardiol; 2015 Nov; 198():87-8. PubMed ID: 26159242
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
    Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
    Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent venous thromboembolism while on anticoagulant therapy.
    Thachil J
    Blood Rev; 2012 Jul; 26(4):175-81. PubMed ID: 22560652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recanalization of lower-limb deep veins as an index of efficacy of treatment for acute venous thrombosis].
    Kuznetsov MR; Sapelkin SV; Boldin BV; Leont'ev SG; Neskhodimov LA
    Angiol Sosud Khir; 2016; 22(3):82-8. PubMed ID: 27626254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home treatment of deep venous thrombosis in the era of new oral anticoagulants.
    Stein PD; Matta F; Hughes PG; Ghiardi M; Marsh JH; Khwarg J; Brandon MS; Fowkes HA; Kazan V; Wiepking M; Keyes DC; Kakish EJ; Hughes MJ
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):729-32. PubMed ID: 26239315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 10 mg warfarin initiation nomogram is safe and effective in outpatients starting oral anticoagulant therapy for venous thromboembolism.
    Monkman K; Lazo-Langner A; Kovacs MJ
    Thromb Res; 2009 Jul; 124(3):275-80. PubMed ID: 19155056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
    Sun P; Dong DN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of administering oral anticoagulants for treatment of patients with venous thromboembolic complications].
    Sukovatykh BS; Sereditskiĭ AV; Muradian VF; Belikov LN; Azarov AM; Gerasimova OF
    Angiol Sosud Khir; 2017; 23(2):82-87. PubMed ID: 28594800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
    Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban.
    Merli GJ; Hollander JE; Lefebvre P; Laliberté F; Raut MK; Olson WH; Pollack CV
    Hosp Pract (1995); 2015; 43(2):85-93. PubMed ID: 25791984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence, indication and compliance with the recommendations of prescription of low molecular weight heparin in oncology].
    Danklou J; Strobbe G; Delbey S; Lefebvre-Kuntz D; Marliot G
    Bull Cancer; 2015 Nov; 102(11):898-905. PubMed ID: 26506036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of the management of venous thromboembolism in Japan].
    Nakamura M
    Nihon Rinsho; 2014 Jul; 72(7):1298-302. PubMed ID: 25163325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Ardeparin Arthroplasty Study Group.
    Heit JA; Berkowitz SD; Bona R; Cabanas V; Corson JD; Elliott CG; Lyons R
    Thromb Haemost; 1997 Jan; 77(1):32-8. PubMed ID: 9031445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CONKO-011: Evaluation of patient satisfaction with the treatment of acute venous thromboembolism with rivaroxaban or low molecular weight heparin in cancer patients. A randomized phase III study].
    Riess H; Sinn M; Kreher S;
    Dtsch Med Wochenschr; 2015 Jun; 140 Suppl 1():S22-3. PubMed ID: 26069043
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of early anticoagulant therapy for venous thromboembolism in polytrauma patients in the acute phase.
    Nakagawa Y; Inokuchi S; Tsuji T; Yamagiwa T; Iizuka S; Morita S; Ootsuka H; Akieda K
    Tokai J Exp Clin Med; 2012 Dec; 37(4):121-5. PubMed ID: 23238904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital length of stay of nonvalvular atrial fibrillation patients who were administered Rivaroxaban versus Warfarin with and without pretreatment parenteral anticoagulants therapies.
    Laliberté F; Pilon D; Raut MK; Nelson WW; Olson WH; Germain G; Schein JR; Lefebvre P
    Hosp Pract (1995); 2014 Aug; 42(3):17-25. PubMed ID: 25255403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.